by Michael Parson | Apr 20, 2022 | MD DrugPro, Pharmacogenomics
Toxicology panels can be run for a variety of reasons but are predominantly used to assess dosing and usage of drugs and medications as well as for diagnostic testing. Toxicology panels are often used for workplace screening, in rehabilitation facilities or for...
by Michael Parson | Sep 23, 2020 | Cancer, Diabetes, Health, Heart Disease, MD DiabeticPro, MD Heartpro, Pharmacogenomics
~As social distancing measures have decreased, demand for medical tests other than COVID-19 increase~ GREENVILLE, SC September 23, 2020 – At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits...
by Michael Parson | Mar 14, 2016 | Pharmacogenomics
Advancements in medical technology are occurring in the field of DNA testing. Technological advancements are making genomic testing faster and more cost-effective. Now these genotype tests can be done simply through a quick swab of a patient’s cheek and physicians can...
by Michael Parson | Jan 28, 2016 | Pharmacogenomics
Since 2007, when the FDA acknowledged that a blood-thinning drug’s effectiveness (or lack of) could be determined by how a person’s unique genetic structure responded to dosage, the medical field has been questioning its trial-by-error methodology....
